Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Mar;11(3):441–448. doi: 10.1128/aac.11.3.441

Pirbenicillin: Comparison with Carbenicillin and BL-P1654, Alone and with Gentamicin, Against Pseudomonas aeruginosa

Carlos E Lopez 1, Harold C Standiford *, Beverly A Tatem 1, Frank M Calia 1, Stephen C Schimpff 1, Merrill J Snyder 1, Richard B Hornick 1
PMCID: PMC352004  PMID: 404963

Abstract

Minimum inhibitory concentrations (MIC) of pirbenicillin against 135 clinical isolates of Pseudomonas aeruginosa were one-fourth of those required for carbenicillin but two times higher than those for BL-P1654. Increasing the inoculum size produced an adverse effect on the bactericidal activity for all three antibiotics. This was more apparent for pirbenicillin than for carbenicillin, but less than the effect on BL-P1654. When concentrations of antibiotics likely to be achieved clinically were used, gentamicin increased the inhibitory and bactericidal effects of all three semisynthetic penicillins for the majority of isolates. Strains highly resistant to the aminoglycoside antibiotic, however, were inhibited no more by the penicillin-gentamicin combinations than by the most effective of the antibiotics alone.

Full text

PDF
441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P., Rodriguez V., Luce J. K. Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci. 1969 Jun;257(6):408–414. doi: 10.1097/00000441-196906000-00007. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Rodriguez V., Weaver S. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity. Antimicrob Agents Chemother. 1976 Apr;9(4):668–674. doi: 10.1128/aac.9.4.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown C. H., 3rd, Natelson E. A., Bradshaw W., Williams T. W., Jr, Alfrey C. P., Jr The hemostatic defect produced by carbenicillin. N Engl J Med. 1974 Aug 8;291(6):265–270. doi: 10.1056/NEJM197408082910601. [DOI] [PubMed] [Google Scholar]
  5. DuPont H. L., Spink W. W. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 Jul;48(4):307–332. doi: 10.1097/00005792-196907000-00003. [DOI] [PubMed] [Google Scholar]
  6. Freid M. A., Vosti K. L. The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med. 1968 May;121(5):418–423. [PubMed] [Google Scholar]
  7. Jordan M. C., Standiford H. C., Kirby W. M. Carbenicillin in treatment of severe infections due to pseudomonas. J Infect Dis. 1970 Sep;122(Suppl):S96+–S96+. doi: 10.1093/infdis/122.supplement_1.s96. [DOI] [PubMed] [Google Scholar]
  8. Klastersky J., Cappel R., Daneau D. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer. 1973 Feb;31(2):331–336. doi: 10.1002/1097-0142(197302)31:2<331::aid-cncr2820310210>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  9. Klastersky J., Vanderklen B., Daneau D., Mathiew M. Carbenicillin and hypokalemia. Ann Intern Med. 1973 May;78(5):774–775. doi: 10.7326/0003-4819-78-5-774. [DOI] [PubMed] [Google Scholar]
  10. Kluge R. M., Standiford H. C., Tatem B., Young V. M., Greene W. H., Schimpff S. C., Calia F. M., Hornick R. B. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974 Oct;6(4):442–446. doi: 10.1128/aac.6.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kluge R. M., Standiford H. C., Tatem B., Young V. M., Schimpff S. C., Greene W. H., Calia F. M., Hornick R. B. The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann Intern Med. 1974 Nov;81(5):584–587. doi: 10.7326/0003-4819-81-5-584. [DOI] [PubMed] [Google Scholar]
  12. Kurtz S., Holmes K., Turck M. Disparity between inhibitory and killing effects of BL-P1654. Antimicrob Agents Chemother. 1975 Feb;7(2):215–218. doi: 10.1128/aac.7.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levine A. S., Schimpff S. C., Graw R. G., Jr, Young R. C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974 Apr;11(2):141–202. [PubMed] [Google Scholar]
  14. Marks M. I., Eickhoff T. C. Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med. 1970 Aug;73(2):179–187. doi: 10.7326/0003-4819-73-2-179. [DOI] [PubMed] [Google Scholar]
  15. McClure P. D., Casserly J. G., Monsier C., Crozier D. Carbenicillin-induced bleeding disorder. Lancet. 1970 Dec 19;2(7686):1307–1308. doi: 10.1016/s0140-6736(70)92264-6. [DOI] [PubMed] [Google Scholar]
  16. Myerowitz R. L., Medeiros A. A., O'Brien T. F. Recent experience with bacillemia due to gram-negative organisms. J Infect Dis. 1971 Sep;124(3):239–246. doi: 10.1093/infdis/124.3.239. [DOI] [PubMed] [Google Scholar]
  17. Overturf G. D., Ressler R., Wilkins J. Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas. Antimicrob Agents Chemother. 1974 Nov;6(5):643–646. doi: 10.1128/aac.6.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Retsema J. A., English A. R., Lynch J. E. Laboratory studies with a new broad-spectrum penicillin, pirbenicillin. Antimicrob Agents Chemother. 1976 Jun;9(6):975–982. doi: 10.1128/aac.9.6.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reyes M. P., Palutke M., Lerner A. M. Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med. 1973 Mar;54(3):413–418. doi: 10.1016/0002-9343(73)90036-3. [DOI] [PubMed] [Google Scholar]
  20. Sanders C. C., Sanders W. E., Jr BL-P1654: a bacteriostatic penicillin? Antimicrob Agents Chemother. 1975 Apr;7(4):435–440. doi: 10.1128/aac.7.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schimpff S. C., Greene W. H., Young V. M., Wiernik P. H. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis. 1974 Nov;130 (Suppl)(0):S24–S31. doi: 10.1093/infdis/130.supplement.s24. [DOI] [PubMed] [Google Scholar]
  22. Schimpff S., Satterlee W., Young V. M., Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971 May 13;284(19):1061–1065. doi: 10.1056/NEJM197105132841904. [DOI] [PubMed] [Google Scholar]
  23. Smith C. B., Wilfert J. N., Dans P. E., Kurrus T. A., Finland M. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin. J Infect Dis. 1970 Sep;122(Suppl):S14–S28. doi: 10.1093/infdis/122.supplement_1.s14. [DOI] [PubMed] [Google Scholar]
  24. Wald E. R., Standiford H. C., Tatem B. A., Calia F. M., Hornick R. B. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1975 Mar;7(3):336–340. doi: 10.1128/aac.7.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES